Ajanta Pharma informs about analyst meet

07 Feb 2025 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ajanta Pharma has informed that it enclosed the schedule of Analyst/Institutional Investor Meeting with the Company. The company has confirmed that the discussion during these meetings will be strictly on the basis of already published information.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2618.50 -12.75 (-0.48%)
28-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...